This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: Thrive Earlier Detection Corp.. Active years: 2022-2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022-2024
Title: Leonardo Hagmann: Innovator in Genomic Testing
Introduction
Leonardo Hagmann is a prominent inventor based in Baltimore, MD (US). He has made significant contributions to the field of genomic testing, holding 2 patents that enhance the accuracy and reliability of personal genomic assessments.
Latest Patents
Hagmann's latest patents focus on barcoded molecular standards. High throughput personal genomic testing has created a need for robust quality control mechanisms to track sample identity, reagent integrity, and other factors with significant influence on assay performance. A method of massively parallel sequencing using an accompanying barcoded molecular standard enables one to track nucleic acid analytes to identify them by project, lot, batch, or patient. The molecular standard contains sequences present in the analyte, allowing it to be processed simultaneously without any other additional reagents. Within the molecular standard, a calibrator sequence permits assessment of fidelity of sequence determination. Additional sequences in the molecular standard may be used to manipulate the molecular standard separate from the analyte. The molecular standard can be used to benchmark sequencing platforms and assess error rates.
Career Highlights
Hagmann is currently associated with Thrive Earlier Detection Corporation, where he continues to innovate in the field of genomic testing. His work is pivotal in advancing the methodologies used in personal genomics.
Collaborations
Some of his notable coworkers include Isaac A Kinde and Howard B Kaufman, who contribute to the collaborative efforts in research and development within the company.
Conclusion
Leonardo Hagmann's contributions to genomic testing through his innovative patents and collaborations highlight his role as a key figure in advancing personal genomics. His work continues to influence the field significantly.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile